Alabi CA - Search Results

1

Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates.

Dong Y, Love KT, Dorkin JR, Sirirungruang S, Zhang Y, Chen D, Bogorad RL, Yin H, Chen Y, Vegas AJ, Alabi CA, Sahay G, Olejnik KT, Wang W, Schroeder A, Lytton-Jean AK, Siegwart DJ, Akinc A, Barnes C, Barros SA, Carioto M, Fitzgerald K, Hettinger J, Kumar V, Novobrantseva TI, Qin J, Querbes W, Koteliansky V, Langer R, Anderson DG. Dong Y, et al. Among authors: alabi ca. Proc Natl Acad Sci U S A. 2014 Mar 18;111(11):3955-60. doi: 10.1073/pnas.1322937111. Epub 2014 Feb 10. Proc Natl Acad Sci U S A. 2014. PMID: 24516150 Free PMC article.

2

Attacking the genome: emerging siRNA nanocarriers from concept to clinic.

Alabi C, Vegas A, Anderson D. Alabi C, et al. Curr Opin Pharmacol. 2012 Aug;12(4):427-33. doi: 10.1016/j.coph.2012.05.004. Epub 2012 Jun 21. Curr Opin Pharmacol. 2012. PMID: 22726555 Review.

3

Efficiency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling.

Sahay G, Querbes W, Alabi C, Eltoukhy A, Sarkar S, Zurenko C, Karagiannis E, Love K, Chen D, Zoncu R, Buganim Y, Schroeder A, Langer R, Anderson DG. Sahay G, et al. Nat Biotechnol. 2013 Jul;31(7):653-8. doi: 10.1038/nbt.2614. Epub 2013 Jun 23. Nat Biotechnol. 2013. PMID: 23792629 Free PMC article.

4

Lipid-like nanomaterials for simultaneous gene expression and silencing in vivo.

Dong Y, Eltoukhy AA, Alabi CA, Khan OF, Veiseh O, Dorkin JR, Sirirungruang S, Yin H, Tang BC, Pelet JM, Chen D, Gu Z, Xue Y, Langer R, Anderson DG. Dong Y, et al. Among authors: alabi ca. Adv Healthc Mater. 2014 Sep;3(9):1392-7. doi: 10.1002/adhm.201400054. Epub 2014 Mar 13. Adv Healthc Mater. 2014. PMID: 24623658 Free PMC article.

5

Synergistic silencing: combinations of lipid-like materials for efficacious siRNA delivery.

Whitehead KA, Sahay G, Li GZ, Love KT, Alabi CA, Ma M, Zurenko C, Querbes W, Langer RS, Anderson DG. Whitehead KA, et al. Among authors: alabi ca. Mol Ther. 2011 Sep;19(9):1688-94. doi: 10.1038/mt.2011.141. Epub 2011 Jul 12. Mol Ther. 2011. PMID: 21750531 Free PMC article.

6

Development of siRNA-probes for studying intracellular trafficking of siRNA nanoparticles.

Alabi CA, Sahay G, Langer R, Anderson DG. Alabi CA, et al. Integr Biol (Camb). 2013 Jan;5(1):224-30. doi: 10.1039/c2ib20155k. Integr Biol (Camb). 2013. PMID: 23014672 Free PMC article.

7

Multiparametric approach for the evaluation of lipid nanoparticles for siRNA delivery.

Alabi CA, Love KT, Sahay G, Yin H, Luly KM, Langer R, Anderson DG. Alabi CA, et al. Proc Natl Acad Sci U S A. 2013 Aug 6;110(32):12881-6. doi: 10.1073/pnas.1306529110. Epub 2013 Jul 23. Proc Natl Acad Sci U S A. 2013. PMID: 23882076 Free PMC article.

8

Effect of molecular weight of amine end-modified poly(β-amino ester)s on gene delivery efficiency and toxicity.

Eltoukhy AA, Siegwart DJ, Alabi CA, Rajan JS, Langer R, Anderson DG. Eltoukhy AA, et al. Among authors: alabi ca. Biomaterials. 2012 May;33(13):3594-603. doi: 10.1016/j.biomaterials.2012.01.046. Epub 2012 Feb 14. Biomaterials. 2012. PMID: 22341939 Free PMC article.

9

FRET-labeled siRNA probes for tracking assembly and disassembly of siRNA nanocomplexes.

Alabi CA, Love KT, Sahay G, Stutzman T, Young WT, Langer R, Anderson DG. Alabi CA, et al. ACS Nano. 2012 Jul 24;6(7):6133-41. doi: 10.1021/nn3013838. Epub 2012 Jun 22. ACS Nano. 2012. PMID: 22693946 Free PMC article.

10

Rationally designed tumor-penetrating nanocomplexes.

Karagiannis ED, Alabi CA, Anderson DG. Karagiannis ED, et al. Among authors: alabi ca. ACS Nano. 2012 Oct 23;6(10):8484-7. doi: 10.1021/nn304707b. ACS Nano. 2012. PMID: 23088785

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

52 results

Search Page